Scholar Rock Holding Corporation (SRRK) Estados Financieros e Histórico

Scholar Rock Holding Corporation (SRRK) — Precio $49.37 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Scholar Rock Holding Corporation (SRRK): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.

Al precio actual de $49.37, SRRK presenta beneficios negativos (P/E no significativo) y un ROE del -160.19%. La capitalización bursátil es de $5.9B.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$37900000$20.5M$15.4M$18.8M$33.2M000
Coste de Ventas$12.5M$669000$807000$54.2M$74.1M$108.5M$123.0M$2.8M$1.9M$208.4M
Beneficio Bruto-$12.1M-$669000-$807000-$33.7M-$58.7M-$89.7M-$89.9M-$2.8M-$1.9M-$208.4M
I+D$12.5M$19.9M$36.3M$54.2M$74.1M$108.5M$124.4M$119.1M$182.6M$208.4M
Generales y Administrativos$4.1M$5.1M$14.4M$20.8M$28.2M$40.3M$42.6M$49.4M$67.5M$176.2M
Gastos Operativos$16.6M$25.0M$50.7M$20.8M$28.2M$40.3M$44.5M$168.5M$250.1M$176.2M
Beneficio Operativo-$16.2M-$25.0M-$50.7M-$54.5M-$86.9M-$129.9M-$134.4M-$171.3M-$252.1M-$384.6M
EBITDA-$15.6M-$24.4M-$49.9M-$53.2M-$85.4M-$129.2M-$129.5M-$162.9M-$237.5M-$369.4M
Gastos por Intereses$190000000000$6.8M$6.9M
Beneficio Antes de Impuestos-$16.2M-$25.0M-$49.3M-$51.0M-$86.5M-$131.8M-$134.5M-$165.8M-$246.3M-$377.9M
Impuestos$19000-$4400000000000
Beneficio Neto-$16.2M-$25.0M-$49.3M-$51.0M-$86.5M-$131.8M-$134.5M-$165.8M-$246.3M-$377.9M
BPA$-0.91$-1.40$-3.15$-1.80$-2.77$-3.59$-2.21$-1.99$-2.47$-3.29
BPA Diluido$-0.91$-1.40$-3.15$-1.80$-2.77$-3.59$-2.21$-1.99$-2.47$-3.29
Acciones en Circulación (Diluidas)$17.9M$17.9M$15.7M$27.5M$30.7M$36.7M$59.6M$76.0M$99.8M$114.7M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos0000
Beneficio Bruto-$50.5M-$46.9M-$3350000
Beneficio Operativo-$103.5M-$91.9M-$102.0M-$108.9M
EBITDA-$100.5M-$88.0M-$102.9M-$105.1M
Beneficio Neto-$102.2M-$91.0M-$105.5M-$109.9M
BPA$-0.90$-0.74$-0.83$-0.84
BPA Diluido$-0.90$-0.74$-0.83$-0.84

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$10.0M$56.5M$115.1M$36.3M$160.4M$212.8M$103.3M$101.9M$177.9M$323.5M
Inversiones a Corto$18.0M$1.5M$60.6M$121.1M$180.7M$40.2M$212.1M$178.1M$259.4M$44.0M
Cuentas por Cobrar000$25.0M00$2.7M$1.1M$2.2M0
Inventario0000000000
Activos Corrientes$28.5M$59.2M$177.9M$185.2M$344.4M$265.3M$328.0M$288.2M$451.2M$385.1M
Inmovilizado Material$2.4M$2.2M$3.2M$8.6M$40.4M$35.0M$25.9M$16.0M$18.4M$12.1M
Fondo de Comercio0000000000
Activos Intangibles0000000$4.1M$2.4M0
Activos Totales$32.8M$61.6M$181.3M$196.4M$388.3M$304.4M$358.2M$311.0M$474.9M$404.3M
Cuentas por Pagar$663000$1.4M$3.3M$1.1M$3.4M$4.4M$4.0M$3.5M$10.1M$10.3M
Deuda a Corto$647000$641000$424000$1.1M0$9.0M0$1.3M0$5.5M
Pasivos Corrientes$3.0M$5.0M$31.1M$32.8M$42.6M$64.3M$36.4M$32.7M$46.9M$55.4M
Deuda a Largo$1.0M$398000$240000$24.7M$48.4M$49.7M$48.7M$50.1M$99.7M
Pasivos Totales$62.8M$115.2M$74.7M$83.5M$127.5M$132.4M$97.9M$85.8M$106.3M$158.8M
Reservas-$32.5M-$57.5M-$106.8M-$157.8M-$244.3M-$376.1M-$510.6M-$676.4M-$922.7M-$1.30B
Patrimonio Neto-$30.0M-$53.5M$106.6M$112.9M$260.8M$172.1M$260.2M$225.2M$368.6M$245.5M
Deuda Total$1.7M$1.0M$462000$5.3M$57.1M$84.5M$69.4M$61.8M$65.1M$108.9M
Deuda Neta-$26.4M-$56.9M-$175.2M-$152.1M-$283.9M-$168.5M-$246.0M-$218.1M-$372.2M-$258.6M
Capital Circulante$25.5M$54.2M$146.8M$152.4M$301.8M$201.0M$291.6M$255.5M$404.2M$329.7M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$286.8M$323.5M$430.5M$437.1M
Activos Totales$411.7M$404.3M$535.3M$523.5M
Pasivos Totales$166.7M$158.8M$259.2M$269.8M
Patrimonio Neto$245.0M$245.5M$276.0M$253.8M
Deuda Total$110.1M$108.9M$205.7M$203.8M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$16.2M-$25.0M-$49.3M-$51.0M-$86.5M-$131.8M-$134.5M-$165.8M-$246.3M-$377.9M
Amortizaciones$575000$669000$807000$1.3M$1.5M$2.6M$3.0M$2.8M$1.9M$1.7M
Compensación en Acciones$556000$1.5M$5.2M$8.0M$11.2M$23.1M$27.7M$27.1M$36.6M$75.6M
Cambio en Capital Circulante$347000$1.5M$67.9M-$21.2M$11.2M-$28.4M-$34.4M-$10.6M$6.6M-$1.1M
Flujo de Caja Operativo-$15.1M-$21.7M$24.6M-$63.1M-$60.3M-$126.8M-$132.7M-$145.2M-$200.9M-$300.0M
Inversiones (CapEx)-$794000-$361000-$1.5M-$3.1M-$4.1M-$5.2M-$1.1M-$71000-$98000-$602000
Adquisiciones0000000000
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$15.9M-$22.1M$23.1M-$66.2M-$64.4M-$132.0M-$133.8M-$145.3M-$201.0M-$300.6M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$68.9M-$75.5M-$82.1M-$69.6M
Inversiones (CapEx)-$84000-$32000-$68000-$1000
Flujo de Caja Libre-$69.0M-$75.5M-$82.2M-$69.6M
Dividendos Pagados0000
Compensación en Acciones$18.3M$19.4M$18.2M$19.7M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)-100.0%-24.8%+22.2%+76.4%-100.0%
Crecimiento Beneficio Neto (anual)-54.2%-97.3%-3.4%-69.6%-52.4%-2.1%-23.3%-48.6%-53.5%
Crecimiento BPA (anual)-53.8%-125.0%+42.9%-53.9%-29.6%+38.4%+10.0%-24.1%-33.2%
Cambio en Acciones (anual)+0.0%-12.6%+75.9%+11.6%+19.4%+62.4%+27.5%+31.4%+14.9%
Crecimiento FCF (anual)-38.7%+204.4%-387.0%+2.8%-105.2%-1.3%-8.6%-38.4%-49.5%
Margen Bruto-3192.1%-164.6%-380.8%-476.5%-270.7%
Margen Operativo-4277.0%-266.2%-564.0%-690.5%-404.8%
Margen EBITDA-4125.3%-259.8%-554.4%-686.5%-390.1%
Margen Neto-4276.3%-248.9%-561.5%-700.5%-405.2%
Margen FCF-4204.5%-323.2%-417.8%-701.7%-403.0%
Tasa Impositiva Efectiva-0.1%0.2%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.89$-1.23$1.47$-2.41$-2.09$-3.60$-2.24$-1.91$-2.01$-2.62
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$17.9M$17.9M$15.7M$27.5M$30.7M$36.7M$59.6M$76.0M$99.8M$114.7M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Rentabilidad

Rentabilidad sobre capital-160.19%
Rentabilidad sobre capital invertido-88.80%
Rentabilidad sobre activos-78.04%
Margen bruto0.00%
Margen operativo0.00%
Margen neto0.00%

Salud financiera

Deuda / Patrimonio0.80
Ratio corriente7.02
Piotroski F-Score1
Altman Z-Score12.43

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-17.03-11.07-7.29-7.32-17.52-6.92-4.10-9.45-17.50-13.39
P/VC-9.24-5.193.373.215.725.302.076.3411.7120.58
P/V732.280.000.0017.7196.8348.4716.250.000.000.00
Margen Bruto-3192.1%0.0%0.0%-164.6%-380.8%-476.5%-270.7%0.0%0.0%0.0%
Margen Operativo-4277.0%0.0%0.0%-266.2%-564.0%-690.5%-404.8%0.0%0.0%0.0%
Margen Neto-4276.3%0.0%0.0%-248.9%-561.5%-700.5%-405.2%0.0%0.0%0.0%

Empresas relacionadas: ADPT · BEAM · CDTX · IDYA · IRON · KNSA · LEGN

Explorar sector: Healthcare · Biotechnology

Más secciones de SRRK: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones